Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting. (Q46123998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Monica Civera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Leonardo Manzoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Daniela Arosio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Donatella Potenza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Michael Pilkington-Miksa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Andrea Caprini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Elena M V Araldi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Eugenia Monferini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Monica Mancino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Francesca Podestà

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Carlo Scolastico

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

615-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212960%20AND%20SRC:MED&resulttype=core&format=json

Role of angiogenesis in tumor growth and metastasis

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

The role of integrins in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Role of integrins in cell invasion and migration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Integrins: bidirectional, allosteric signaling machines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Arg-Gly-Asp: a versatile cell recognition signal

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Ligand binding to integrins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

The ligand recognition specificity of beta3 integrins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Cyclic RGD peptides ameliorate ischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Crystal structure of the extracellular segment of integrin alpha Vbeta3

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Carbohydrate Derivatives for Use in Drug Design: Cyclicαv-Selective RGD Peptides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Are β-Amino Acids γ-Turn Mimetics? Exploring A New Design Principle for Bioactive Cyclopeptides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Synthesis of substituted conformationally constrained 6,5- and 7,5-fused bicyclic lactams as dipeptide mimics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Stereoselective synthesis of Cα-tetrasubstituted azabicyclo[X.3.0]alkane amino acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Functionalized azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

A potent integrin antagonist from a small library of cyclic RGD pentapeptide mimics including benzyl-substituted azabicycloalkane amino acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Integrins and angiogenesis: a sticky business

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Turns in peptides and proteins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Semianalytical treatment of solvation for molecular mechanics and dynamics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Transferred-NOE NMR experiments on intact human platelets: receptor-bound conformation of RGD-peptide mimics.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

An all atom force field for simulations of proteins and nucleic acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

An efficient newton-like method for molecular mechanics energy minimization of large molecules

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021

Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800422

7 January 2021